2-Amino-2-oxazolines, part VIII. Calculated molecular properties of tautomeric species

Archiv der Pharmazie

Volumn 330, Issue 12, 1997, Pages 367-371

  Ouhabi, Jamal ^a,b   Jarry, Christian ^a   Zouanate, Abdelhadi ^b   Carpy, Alain ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b FACULTÉ DES SCIENCES ET TECHNIQUES GUÉLIZ   (Morocco)

Author keywords

2 Amino 2 oxazoline; Molecular electrostatic lipophilicity potential; Semiempirical and ab initio calculations; Tautomerism

Indexed keywords

2 AMINO 2 OXAZOLINE DERIVATIVE; OXAZOLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; DIPOLE; DRUG STABILITY; DRUG STRUCTURE; GEOMETRY; IN VITRO STUDY; INTERMETHOD COMPARISON; LIPOPHILICITY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

EID: 0031437263     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/ardp.19973301202     Document Type: Article

References (26)

1. C. Ögretir, S. Yarligan, J. Mol. Struct. (Theochem) 1996, 366, 227-231 and references cited herein.
2. M. Speranza, Adv. Het. Chem. 1985, 40, 25-97.
3. C. Misiaszek, C. Jarry, E. Panconi, A. Carpy, Eur. J. Med. Chem. 1990, 25, 379-382.
4. B. Vaugien, P. Descas, P. Gomond, B. Lambrey, C. D'Arnoux, C. Jarry, J. Mosser, E. Panconi, F. Sandubray, J. Roux, Drugs Future 1991, 16, 893-894.
5. J.J. Bosc, C. Jarry, A. Carpy, E. Panconi, P. Descas, Eur. J. Med. Chem. 1992, 27, 437-442.
6. J.J. Bosc, C. Jarry, J. Ouhabi, M. Laguerre, A. Carpy, Can. J. Chem. 1996, 74, 1341-1347.
7. M. Orozco, F.J. Luque, J. Comput. Chem. 1990, 11, 909-923.
8. B.H. Besler, K.M. Merz, P.A. Kollman, J. Comput. Chem. 1990, 11, 431-439.
9. W.M.F. Fabian, Z. Naturforsch. 1990, 45a, 1328-1334.
10. J.J.P. Stewart, J. Comput. Chem. 1989, 10, 209-221.
11. J. Garcia, J. Vilarrasa Heterocycles 1988, 27, 1803-1807.
12. N.L., Allinger, J. Am. Chem. Soc. 1977, 99, 8127-8134.
13. Macro Model, distributed by Columbia University, New York.
14. C. Jarry, J.J. Bosc, J. Ouhabi, A. Carpy, Arch. Pharm (Weinheim) 1990, 323, 157-161.
15. I. Forfar, C. Jarry, J.P. Fayet, A. Carpy, Arch. Pharm. (Weinheim) 1992, 325, 541-543.
16. C. Giessner-Prettre, Quantum Chemistry Programme Exchange 1974, 249.
17. Insight 2, distributed by Biosym Technologies Inc., San Diego, CA.
18. P. Broto, G. Moreau, C. Vandycke, Eur. J. Med. Chem. 1984, 19, 71-78.
19. E. Audry, J.P. Dubost, J.C. Colleter, Ph. Dallet. Eur. J. Med. Chem. 1986, 21, 71-72.
20. J.L., Fauchere, P. Quarendon, L. Kaetterer, J. Mol. Graphics 1988, 6, 203-206.
21. J.P. Dubost, in Trends in QSAR and Molecular Modelling 92 (Ed.: C.G. Wermuth). ESCOM, Leiden. 1993, p. 93.
22. P.R. Andrews, S.L.A. Munro, M. Sadek, M.G. Wong, J. Chem. Soc. Perkin Trans. II, 1988, 711-718.
23. M.J.S. Dewar, W.H. Thiel, J. Am. Chem. Soc. 1977, 99, 4907-4919.
24. A. Goldblum, J. Comput. Chem. 1987, 8, 835-843.
25. M.J.S. Dewar, G. Zoebisch, E.F. Healy, J.J.P. Stewart, J. Am. Chem. Soc. 1985, 107, 3902-3911.
26. M.W. Schmidt, K.K. Baldridge, J.A. Boatz, S.T. Elbert, M.S. Gordon, J.H. Jensen, S. Koseki, N. Matsunaga, K.A. Nguyen, S.J. Su, T.L. Windus, M. Dupuis, J.A. Montgomery, J. Comput. Chem. 1993, 14, 1347-1363, GAMESS Version, 1995 for CRAY (UNICOS).